CN112480282A - Cyclocarya paliurus polysaccharide component and preparation method thereof - Google Patents
Cyclocarya paliurus polysaccharide component and preparation method thereof Download PDFInfo
- Publication number
- CN112480282A CN112480282A CN202011550098.XA CN202011550098A CN112480282A CN 112480282 A CN112480282 A CN 112480282A CN 202011550098 A CN202011550098 A CN 202011550098A CN 112480282 A CN112480282 A CN 112480282A
- Authority
- CN
- China
- Prior art keywords
- cyclocarya paliurus
- polysaccharide component
- polysaccharide
- solution
- cyclocarya
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000233779 Cyclocarya paliurus Species 0.000 title claims abstract description 128
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 118
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 118
- 150000004676 glycans Chemical class 0.000 title claims abstract description 117
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000000502 dialysis Methods 0.000 claims abstract description 14
- 238000001035 drying Methods 0.000 claims abstract description 14
- 238000001556 precipitation Methods 0.000 claims abstract description 8
- 150000002772 monosaccharides Chemical class 0.000 claims abstract description 6
- 238000003809 water extraction Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000000605 extraction Methods 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 6
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 claims description 5
- 238000004440 column chromatography Methods 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims 2
- 238000001291 vacuum drying Methods 0.000 claims 2
- 238000005119 centrifugation Methods 0.000 claims 1
- 230000002218 hypoglycaemic effect Effects 0.000 claims 1
- 241000233778 Cyclocarya Species 0.000 abstract description 2
- 239000003472 antidiabetic agent Substances 0.000 abstract description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 30
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 13
- 108010028144 alpha-Glucosidases Proteins 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 7
- 229960002632 acarbose Drugs 0.000 description 7
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 7
- IFBHRQDFSNCLOZ-IIRVCBMXSA-N 4-nitrophenyl-α-d-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-IIRVCBMXSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 3
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000012869 ethanol precipitation Methods 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- UBXYXCRCOKCZIT-UHFFFAOYSA-N biphenyl-3-ol Chemical group OC1=CC=CC(C=2C=CC=CC=2)=C1 UBXYXCRCOKCZIT-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- -1 polysaccharide compound Chemical class 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Sustainable Development (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a cyclocarya paliurus polysaccharide component, wherein monosaccharides of the cyclocarya paliurus polysaccharide component are in the following weight ratio: glc (20.96%), GalUA (14.71%), Gal (23.75%), Ara (17.9%), Man (7.8%), Rha (6.88%), GlcUA (4.43%), Xyl (1.67%), Fuc (1.9%) with an average molecular weight of 700D for the cyclocarya polysaccharide fraction. The preparation method mainly comprises five steps of water extraction, alcohol precipitation, dialysis, fractionation and drying. The cyclocarya paliurus polysaccharide component is applied to preparing the hypoglycemic drug.
Description
Technical Field
The invention relates to a cyclocarya paliurus polysaccharide component and a preparation method thereof.
Background
Cyclocarya paliurus (Batal) Iljinskaja is a plant of Cyclocarya of Juglandaceae, also called sweet tea tree, Qingqian plum, and Cyclocarya paliurus, and is widely distributed in Jiangxi, Guizhou, Hunan and other places in China. Cyclocarya paliurus is a specific medicinal plant in China, has the effects of clearing heat and removing toxicity, promoting fluid production to quench thirst, relieving summer heat, relieving pain and the like, and can be used for treating intractable tinea. Cyclocarya paliurus contains various chemical components, mainly including flavonoid, polysaccharide, triterpenes, organic acids, inorganic elements and the like. Cyclocarya paliurus polysaccharide is a bioactive component with multiple physiological functions in cyclocarya paliurus leaves. The study shows that the cyclocarya paliurus polysaccharide compound has various biological activities of reducing blood sugar, resisting tumors, reducing blood pressure, resisting oxidation, improving human immunity and the like.
The method for separating and purifying polysaccharide mainly comprises ethanol precipitation, ion exchange resin method, gel filtration column chromatography, affinity chromatography, and membrane separation. Chenxylon et al used different types of resin to separate and purify cyclocarya paliurus polysaccharide, preliminarily determined that D301R resin has a good purification effect, xie et al used membrane separation combined with gel permeation chromatography to separate cyclocarya paliurus polysaccharide into four components.
The alpha-glucosidase inhibitor can effectively control blood sugar and has exact treatment effect on I, II type diabetes. Alpha-glucosidase is an important enzyme involved in sugar metabolism in human bodies, and when carbohydrates such as starch, sucrose and the like enter gastrointestinal tracts, the carbohydrates are degraded into glucose by the alpha-glucosidase and can be absorbed by mucous membranes to enter metabolic cycle. The action mechanism of the alpha-glucosidase inhibitor is to generate competitive inhibition to alpha-glucosidase and reduce the generation rate of glucose, so that the blood sugar of a diabetic patient is stable and maintained at a certain level. Foreign studies have confirmed that acarbose is a representative drug for α -glucosidase inhibitors. At present, the research on the inhibition of alpha-glucosidase by cyclocarya paliurus polysaccharide mainly focuses on the research on the activities of total polysaccharide and ethanol precipitation products with different concentrations, and the research on the pharmacological activity of obtaining uniform polysaccharide components through a DEAE-cellulose ion exchange column does not exist.
Disclosure of Invention
One of the purposes of the invention is to provide a cyclocarya paliurus polysaccharide component, the inhibition rate of the component on alpha-glucosidase is higher than that of total polysaccharide of cyclocarya paliurus, the problems of complex components, large molecular weight, undefined sugar-reducing part and the like of the total polysaccharide of cyclocarya paliurus are solved, and the obtained component has a stable structure.
The polysaccharide component of the cyclocarya paliurus comprises the following monosaccharides in percentage by weight:
the average molecular weight is 700D.
The invention also aims to provide the application of the cyclocarya paliurus polysaccharide component in preparing the hypoglycemic drug. Pharmacological results show that the polysaccharide component of the cyclocarya paliurus can obviously inhibit a-glucosidase, and the effect of the polysaccharide component is better than that of acarbose and total polysaccharide of the cyclocarya paliurus.
The invention also aims to provide a preparation method of the cyclocarya paliurus polysaccharide component, which comprises the following steps:
1. water extraction: taking a proper amount of cyclocarya paliurus stem, branch and leaf, adding 15-25 times of water, preferably 25 times of water, carrying out reflux heating extraction at 100 ℃, wherein the extraction time is 1-3 hours, preferably 1 hour, the extraction frequency is 1-3 times, preferably 3 times, and after the extraction is finished, combining all water extract to obtain cyclocarya paliurus water extract; centrifuging for 15min at 4000 r/min;
2. alcohol precipitation and drying: concentrating the cyclocarya paliurus water extract to obtain cyclocarya paliurus concentrated solution, adding 95% ethanol for alcohol precipitation, wherein the concentration of the ethanol for alcohol precipitation is 60% -80%, preferably 70%, standing in the shade overnight, removing supernatant, and drying the precipitate under reduced pressure to obtain cyclocarya paliurus total polysaccharide;
3. and (3) dialysis: dissolving the obtained total cyclocarya paliurus polysaccharides, centrifuging, taking supernate, dialyzing by a dialysis bag with the density of 1KD to obtain a cyclocarya paliurus polysaccharide component 1 solution in the dialysis bag and a cyclocarya paliurus polysaccharide component 2 solution outside the dialysis bag, concentrating, freeze-drying, and respectively obtaining a cyclocarya paliurus polysaccharide component 1 and a cyclocarya paliurus polysaccharide component 2;
4. and (3) fractional separation: dissolving the cyclocarya paliurus polysaccharide component 1, performing DEAE-cellulose column chromatography, eluting with pure water and 0.2-0.5 mol/L NaCl in sequence, preferably 0.5mol/L to obtain cyclocarya paliurus polysaccharide component 3 solution and cyclocarya paliurus polysaccharide component 4 solution;
5. and (3) drying: and (3) concentrating and drying the obtained polysaccharide component 3 solution under reduced pressure to obtain the cyclocarya paliurus polysaccharide component.
The method for separating and purifying the cyclocarya paliurus polysaccharide component is simple, the monosaccharide content and the molecular weight range of the polysaccharide component are clear, the structure is stable, and pharmacological results show that the cyclocarya paliurus polysaccharide component can obviously inhibit a-glucosidase, and the effect of the polysaccharide component is better than that of acarbose and total polysaccharide of cyclocarya paliurus.
Drawings
FIG. 1 shows the molecular weight ranges of different polysaccharide components of cyclocarya paliurus.
Detailed Description
Example 1 cyclocarya paliurus polysaccharide fraction preparation.
1. The polysaccharide component of the cyclocarya paliurus is separated and purified by the following steps: taking a proper amount of cyclocarya paliurus stems and branches, adding 15-25 times of water, carrying out reflux heating extraction at 100 ℃, wherein the extraction time is 1-3 hours, the extraction times are 1-3 times, and combining all water extracts after the extraction is finished; concentrating the cyclocarya paliurus extract, adding 95% ethanol for alcohol precipitation, keeping the alcohol concentration of the alcohol precipitation to be 60% -80%, standing overnight in a shade place, removing the supernatant, taking the precipitate, and drying under reduced pressure to obtain 50.61g of cyclocarya paliurus total polysaccharide. Dissolving cyclocarya paliurus total polysaccharide in 10 times of distilled water, stirring overnight for full dissolution, 4000r/min, and centrifuging for 15min to obtain precipitate (impurity 6.9g) and supernatant (dissolved cyclocarya paliurus total polysaccharide). And (3) dialyzing the obtained supernatant (cyclocarya paliurus total polysaccharide) by a dialysis bag with the KD of 1KD to obtain a cyclocarya paliurus polysaccharide component 1 in the bag and a cyclocarya paliurus polysaccharide component 2 solution outside the bag. And (3) concentrating and drying the cyclocarya paliurus polysaccharide component 1 solution and the cyclocarya paliurus polysaccharide component 2 solution under reduced pressure to obtain a cyclocarya paliurus polysaccharide component 1(23.4g) and a cyclocarya paliurus polysaccharide component 2(14.8 g). Dissolving the cyclocarya paliurus polysaccharide component 1(18g), performing DEAE-cellulose column chromatography, and eluting with pure water and 0.2-0.5 Mol/L NaCl in sequence to obtain cyclocarya paliurus polysaccharide component 3 solution and cyclocarya paliurus polysaccharide component 4 solution; concentrating all polysaccharide component solutions under reduced pressure, and drying to obtain cyclocarya paliurus polysaccharide component 3(7.6g) and cyclocarya paliurus polysaccharide component 4(3.4 g).
2. And identifying the total polysaccharide of cyclocarya paliurus and the component structures of each polysaccharide of cyclocarya paliurus.
(1) And (3) analyzing the composition content: analyzing the sugar component content of the prepared cyclocarya paliurus total polysaccharide and cyclocarya paliurus polysaccharide component 1, cyclocarya paliurus polysaccharide component 2, cyclocarya paliurus polysaccharide component 3 and cyclocarya paliurus polysaccharide component 4 in the step 1, specifically determining the sugar content by adopting a phenol-sulfuric acid method, determining the uronic acid content by adopting an m-hydroxybiphenyl method, and determining the protein content by adopting a Coomassie brilliant blue method, wherein the specific results are as follows:
TABLE 1 Total polysaccharide of cyclocarya paliurus and the composition content of each polysaccharide component of cyclocarya paliurus
(2) And (3) monosaccharide composition determination: and (2) performing monosaccharide composition analysis on the prepared cyclocarya paliurus total polysaccharide in the step 1, the cyclocarya paliurus polysaccharide component 2, the cyclocarya paliurus polysaccharide component 3 and the cyclocarya paliurus polysaccharide component 4, and determining by adopting high performance liquid chromatography. The method comprises the following specific steps: using a Shimadzu HPLC system (LC-10ATvp pump and SPD-10AVD UV detector), Compass C18 chromatography column (4.6X 150mm), PBS (0.1M, pH 7.0-acetonitrile 81:19(v/v), flow rate of 1.0mL/min, sample size of 10. mu.L, detection wavelength of 245 nm.
TABLE 2 Total polysaccharide of cyclocarya paliurus and the polysaccharide composition and content in each of the polysaccharide components of cyclocarya paliurus
(3) And (3) measuring the molecular weight: the molecular weights of the cyclocarya paliurus total polysaccharide prepared in the step 1, the cyclocarya paliurus polysaccharide component 2, the cyclocarya paliurus polysaccharide component 3 and the cyclocarya paliurus polysaccharide component 4 are determined by adopting a high-efficiency gel permeation chromatography, and the specific method comprises the following steps: an LC-10Avp high performance liquid chromatograph system manufactured by Shimadzu corporation of Japan, an RID-10A parallax refraction detector, a Shimadzu CLASS-Vp workstation, a TSK-gel G-3000PWXL stainless steel chromatographic column (7.8X 300mm) with a column temperature of 40 ℃ are adopted. A cyclocarya paliurus polysaccharide sample is dissolved in a 0.2M NaCl aqueous solution, the concentration is 2mg/mL, and the loading amount is 20 mu L. The mobile phase was 0.2M aqueous NaCl at a flow rate of 0.6 mL/min. The molecular weight distribution results of the fractions are shown in FIG. 1.
Example 2: cyclocarya paliurus polysaccharide a-glucosidase inhibition experiment
Experimental materials and preparation of (i) phosphate buffer (PH 6.8): precision measuring K2HPO4(0.2mol/L) solution and KH2PO4(0.2mol/L) solution, and uniformly mixing; preparing a test solution: precisely weighing 0.5g of sample, and preparing into solution with concentration of 5.0, 10.0, 20.0, 40.0, 80.0, 160.0 μ g/ml with phosphate buffer solution; preparing an alpha-glucosidase solution: accurately weighing alpha-glucosidase powder, and preparing the alpha-glucosidase powder into 0.04U/ml alpha-glucosidase solution by using a phosphate buffer solution; preparation of substrate solution: precisely weighing 7.52g of PNPG powder, and preparing the PNPG powder into a solution with the concentration of 0.5mM by using a phosphate buffer solution; preparing a positive medicine acarbose solution: precisely weighing acarbose, and preparing into a solution with the concentration of 2mg/ml by using a phosphate buffer solution; sixth of ten2CO3Preparation of the solution: precisely weighing Na2CO3The powder was added with distilled water to prepare a solution having a concentration of 0.1mol/L (PH 9.8).
The experimental steps are as follows: firstly, precisely sucking 40 mul of test solution with different concentrations into a 96-well plate, adding 40 mul of alpha-glucosidase solution, incubating for 5min in a constant temperature box at 37 ℃, respectively adding 20 mul of PNPG solution, and shaking to be uniform to serve as the test solution (six times in parallel). Three groups are used as test groups, and three groups are used as test article background groups. Precisely pipette 40. mu.l of acarbose into a 96-well plate (six replicates), three groups were used as experimental groups and three groups were used as positive drug background groups. The test group is added with 40 mul of alpha-glucosidase solution, incubated for 5min at constant temperature of 37 ℃, added with 20 mul of PNPG solution and shaken evenly. Precisely sucking 40 mu l of buffer solution into a 96-well plate, adding 40 mu l of alpha-glucosidase solution, incubating at constant temperature of 37 ℃ for 5min, adding 20 mu l of PNPG solution, shaking uniformly to serve as negative control (six times in parallel), using three groups as negative control groups, and using three groups as negative background groups. Placing the sample in a constant temperature and humidity incubator, incubating at 37 deg.C for 40min, adding Na2CO3The reaction was stopped with 100. mu.l of the solution. Detecting the sample to be detected with enzyme linked immunosorbent assay (ELISA) detector with detection wavelength of 405nm, and recording OAnd D value.
Subject: respectively are cyclocarya paliurus total polysaccharides; cyclocarya paliurus polysaccharide component 1; cyclocarya paliurus polysaccharide component 2; cyclocarya paliurus polysaccharide component 3; cyclocarya paliurus polysaccharide component 4
TABLE 3 comparison of the inhibitory Activity of the total polysaccharide of cyclocarya paliurus and the polysaccharide component a-glucosidase of cyclocarya paliurus
And (4) conclusion: the activity test shows that the cyclocarya paliurus total polysaccharide and the cyclocarya paliurus component have alpha-glucosidase inhibition activity, but the cyclocarya paliurus component 3 has the strongest activity, and the activity is stronger than that of a control drug acarbose and cyclocarya paliurus total polysaccharide.
Claims (5)
1. The polysaccharide component of the cyclocarya paliurus is characterized by comprising the following monosaccharides in percentage by weight:
the average molecular weight is 700D.
2. Use of the cyclocarya paliurus polysaccharide fraction of claim 1 in the preparation of a hypoglycemic medicament.
3. A method of preparing a cyclocarya paliurus polysaccharide fraction as claimed in claim 1 or 2, comprising the steps of:
(1) water extraction: extracting stem, branch and leaf of cyclocarya paliurus medicinal material with water to obtain cyclocarya paliurus water extract;
(2) alcohol precipitation and drying: concentrating cyclocarya paliurus water extract, precipitating with ethanol, standing overnight, centrifuging to obtain precipitate, and vacuum drying to obtain cyclocarya paliurus total polysaccharide;
(3) and (3) dialysis: dissolving the obtained cyclocarya paliurus total polysaccharide, centrifuging, taking supernate, dialyzing by a dialysis bag with the density of 1KD to obtain cyclocarya paliurus polysaccharide component 1 solution in the dialysis bag and cyclocarya paliurus polysaccharide component 2 solution outside the dialysis bag, concentrating, freeze-drying and respectively obtaining cyclocarya paliurus polysaccharide component 1 and cyclocarya paliurus polysaccharide component 2;
(4) and (3) fractional separation: dissolving the cyclocarya paliurus polysaccharide component 1, performing DEAE-cellulose column chromatography, and eluting with pure water and 0.2-0.5 mol/L NaCl in sequence to obtain cyclocarya paliurus polysaccharide component 3 solution and cyclocarya paliurus polysaccharide component 4 solution;
(5) and (3) drying: and (3) drying the cyclocarya paliurus polysaccharide component 3 solution under reduced pressure to obtain the cyclocarya paliurus polysaccharide component.
4. The method of preparing a cyclocarya paliurus polysaccharide component of claim 3, wherein: the water extraction step in the step (1) is as follows: taking a proper amount of cyclocarya paliurus stems, branches and leaves, crushing, adding 15-25 times of water, carrying out reflux heating extraction at 100 ℃, wherein the extraction time is 1-3 hours, the extraction times are 1-3 times, and after the extraction is finished, combining all water extracts to obtain a cyclocarya paliurus water extract;
and (3) centrifuging for 15min under the centrifugation condition of 4000r/min in the step (2).
5. A method of preparing a cyclocarya paliurus polysaccharide component of claim 3 or claim 4, wherein:
(1) water extraction: taking a proper amount of cyclocarya paliurus stems, branches and leaves, crushing, adding 25 times of water, carrying out reflux heating extraction at 100 ℃, wherein the extraction time is 1h, the extraction times are 3 times, and after the extraction is finished, combining all water extracts to obtain a cyclocarya paliurus water extract;
(2) alcohol precipitation and drying: concentrating cyclocarya paliurus water extract, precipitating with ethanol, standing overnight, centrifuging to obtain precipitate, and vacuum drying to obtain cyclocarya paliurus total polysaccharide;
(3) and (3) dialysis: dissolving the obtained cyclocarya paliurus total polysaccharide, centrifuging, taking supernate, dialyzing by a dialysis bag with the density of 1KD to obtain cyclocarya paliurus polysaccharide component 1 solution in the dialysis bag and cyclocarya paliurus polysaccharide component 2 solution outside the dialysis bag, concentrating, freeze-drying and respectively obtaining cyclocarya paliurus polysaccharide component 1 and cyclocarya paliurus polysaccharide component 2;
(4) and (3) fractional separation: dissolving the cyclocarya paliurus polysaccharide component 1, performing DEAE-cellulose column chromatography, and eluting with pure water and 0.5mol/L NaCl in sequence to obtain cyclocarya paliurus polysaccharide component 3 solution and cyclocarya paliurus polysaccharide component 4 solution;
(5) and (3) drying: and (3) drying the cyclocarya paliurus polysaccharide component 3 solution under reduced pressure to obtain the cyclocarya paliurus polysaccharide component.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011550098.XA CN112480282A (en) | 2020-12-24 | 2020-12-24 | Cyclocarya paliurus polysaccharide component and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011550098.XA CN112480282A (en) | 2020-12-24 | 2020-12-24 | Cyclocarya paliurus polysaccharide component and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112480282A true CN112480282A (en) | 2021-03-12 |
Family
ID=74914388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011550098.XA Pending CN112480282A (en) | 2020-12-24 | 2020-12-24 | Cyclocarya paliurus polysaccharide component and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112480282A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116655822A (en) * | 2023-06-20 | 2023-08-29 | 江西农业大学 | Dextran, preparation method thereof, antioxidant reagent, immunoregulatory reagent and application |
-
2020
- 2020-12-24 CN CN202011550098.XA patent/CN112480282A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116655822A (en) * | 2023-06-20 | 2023-08-29 | 江西农业大学 | Dextran, preparation method thereof, antioxidant reagent, immunoregulatory reagent and application |
| CN116655822B (en) * | 2023-06-20 | 2024-06-11 | 江西农业大学 | Dextran, preparation method thereof, antioxidant reagent, immunoregulatory reagent and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11111317B2 (en) | Cordyceps militaris medium polysaccharide, method for separating and purifying same, and use thereof | |
| Pitchaipillai et al. | In vitro antidiabetic activity of ethanolic leaf extract of bruguiera Cylindrica L.–glucose uptake by yeast cells method | |
| US10835552B2 (en) | Method for preparing linseed polysaccharide having antiviral activity and immunological activity, and use of the linseed polysaccharide | |
| CN112457424B (en) | Preparation method and application of liquorice polysaccharide effective part | |
| CN111700902B (en) | Hawthorn procyanidine-jujube polysaccharide composition and preparation method thereof | |
| CN108164614B (en) | Preparation method of gelidium amansii polysaccharide with immunoregulation effect, structural part characterization and application thereof | |
| CN112480282A (en) | Cyclocarya paliurus polysaccharide component and preparation method thereof | |
| CN104107187A (en) | Application of apocynum venetum acidic polysaccharide to medicines for treating diabetes | |
| CN112076207B (en) | High molecular weight cordyceps militaris polysaccharide, preparation method thereof and application of high molecular weight cordyceps militaris polysaccharide in preparation of anticomplement medicines | |
| Sarkar et al. | Evaluation of in vitro anti diabetic activity of two mangrove plant extracts: Heritiera fomes and Sonneratia apetala | |
| CN113717296A (en) | Eucommia acidic polysaccharide, extraction method and application of eucommia acidic polysaccharide in preparation of anti-colon cancer drugs | |
| Gong et al. | Effects of crude flavonoids from tatary buckwheat on alloxan-induced oxidative stress in mice | |
| CN115894735B (en) | Eagle tea acidic polysaccharide, extraction and purification method and anticancer application thereof | |
| NL2032676B1 (en) | Neutral oligosaccharide cordyceps militaris for regulating lung lymphocyte differentiation, preparation method and applications thereof | |
| CN103275237A (en) | Preparation method and application of eggplant branch polysaccharide | |
| CN107913297B (en) | Microcos paniculata flavone C-glycoside composition and preparation method and application thereof | |
| CN104910291A (en) | Jackfruit leaf polysaccharide as well as preparation method and application thereof | |
| CN104004109A (en) | Ocean sulfated glycosaminoglycan SE-3 and preparation method thereof | |
| CN104945533B (en) | A kind of preparation method of active corn stigma holosaccharide | |
| CN112979839A (en) | Preparation method of passion flower leaf acidic polysaccharide | |
| CN110498863B (en) | Ficus pumila leaf polysaccharide, preparation method thereof and application thereof in preparation of anticomplement medicines | |
| CN100417390C (en) | Effective part of sweet wormwood, its preparation method and application thereof in pharmacy | |
| CN111732672B (en) | Okra polygalacturonic acid with uric acid reducing effect and preparation method and application thereof | |
| CN116731217B (en) | Ampelopsis grossedentata acidic polysaccharide AGP-2a, preparation method thereof and application thereof in preparing anti-inflammatory cosmetics | |
| CN110483653B (en) | Preparation method of lentinan component with immunocompetence, product and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210312 |